coffea arabica D12

Coffea arabica D12 is a homeopathic medicinal product developed by Biologische Heilmittel Heel GmbH. It is prepared from the unroasted dried seeds of the coffee plant through a process of serial decimal dilution and succussion to a D12 potency (representing a 10^-12 dilution). Its primary indication is the short-term treatment of insomnia, particularly when sleep difficulty is associated with mental overactivity, a rapid flow of ideas, or nervous excitability. The preparation follows the homeopathic principle of "similia similibus curentur" (like cures like), where a substance that causes certain symptoms in healthy individuals (such as the wakefulness induced by coffee) is used in highly diluted form to treat similar symptoms in patients. As a homeopathic preparation at this dilution level, it does not have a conventional pharmacological mechanism of action involving molecular targets.

Brand names

Coffea-Injeel

Other names

Coffea cruda D12Coffea D12